Le Lézard
Classified in: Health
Subject: SCZ

Local Seniors' Community Resident Celebrates 109th Birthday


SURREY, BC, Sept. 25, 2019 /CNW/ - Amenida Seniors' Community resident, Mr. Ja Hyung Lee celebrated his 109th birthday with a special celebration at his care home this past week. Mr. Lee, who was born in South Korea, still plays pool, bingo, and takes the bus on his own.

Mr. Ja Hyung Lee celebrating his 109th birthday with Amenida Seniors' Community owner, Dr. Peter Chung. (CNW Group/Primacorp Ventures Inc.)

Amenida Seniors' Community and the centre's owner, Dr. Peter Chung, hosted a birthday celebration to mark this amazing milestone with MLA Harry Bains and Senator Yonah Martin in attendance. Greetings were also sent from Premier John Horgan.

Family and friends shared a celebratory meal and cake with Mr. Lee - and sang Happy Birthday in both Korean and English.

"We were honoured to have the opportunity to share in such a special milestone with Mr. Lee," said Dr. Chung. "We would all be lucky to live a life as full as his has been."

Amenida Seniors' Community, a division of Primacorp Ventures, has provided supportive living for seniors for more than 20 years. Located in the Newton area of Surrey, the centre provides a range of options for its residents including independent living, assisted living, and respite services. In addition to recreational activities like gardening, billiards, exercise classes, and more, Amenida also offers Korean residents with the option of choosing from a Korean menu for their meals.

Catch a glimpse of Mr. Lee's birthday festivities from the coverage from CTV News: https://bc.ctvnews.ca/video?clipId=1785904

About Primacorp Ventures:
Established in 1995, Primacorp invests in and manages businesses across a broad spectrum including the largest accredited independent post-secondary education group in Canada, on-line and distance educations programs, real estate acquisition and development, private seniors' homes, and corporate branding and marketing operations. Most recently, Primacorp expanded into Social Enterprise and continues to grow and expand into education, service and care businesses in Canada and abroad.

Established in 1995, Primacorp invests in and manages businesses across a broad spectrum including the largest accredited independent post-secondary education group in Canada, on-line and distance educations programs, real estate acquisition and development, private seniors' homes, and corporate branding and marketing operations. Most recently, Primacorp expanded into Social Enterprise and continues to grow and expand into education, service and care businesses in Canada and abroad. (CNW Group/Primacorp Ventures Inc.)

SOURCE Primacorp Ventures Inc.


These press releases may also interest you

at 16:12
SummaryProducts: Cetrotide 0.25mg Issue: One lot of Cetrotide 0.25mg is being recalled because some vials may have missing stoppers, which could make the product unsterile. What to do: Check the lot number on your product or contact your pharmacist...

at 12:00
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 105,091 cases of COVID-19 in Canada, including 8,663 deaths. 65% of people have now recovered....

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 102 new cases over the past 24 hours, bringing the total number of people infected to 55,784. During the same period, 3 new deaths were recorded, to which are added 3 deaths that occurred...

at 10:37
On Friday, the British government announced that, as of July 10th, those travelling from the Commonwealth of Dominica to England need not self-isolate for 14 days. Dominica is one of the 59 countries and 14 British Overseas Territories forming a...

at 03:05
Gilead Sciences, Inc. today announced data from an ongoing Phase 1 study, which showed that a sustained-delivery subcutaneous formulation of the company's investigational, novel inhibitor of HIV-1 capsid function, lenacapavir (GS-6207), sustained...

at 03:05
Gilead Sciences, Inc. today announced data demonstrating the safety and efficacy of the once-daily, single tablet regimen Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) in virologically suppressed...



News published on 25 september 2019 at 08:00 and distributed by: